Articles By Rob Wright, Chief Editor 2011-2021

The Keys To Innovation
Fast Company recently released its 2011 list of most innovative companies. In the biotech sector, the top five innovators include Amyris, Omeros, Synthetic Genomics, Galapagos, and Amgen. With the exception of Amgen, I have to admit, I was unfamiliar with the other four companies listed.  Continue Reading..
  • Courting, Networking, And Diversity
    5/12/2011

    The royal wedding is now behind us, but that hasn’t stopped us from doing our own form of courting here at Life Science Leader magazine. We recently added two new contributing editors, Wayne Koberstein and Sara Gambrill. Many of you might recognize Wayne, former editor in chief for Pharmaceutical Executive and BioExecutive International magazines.

  • Why The HBA Women Of The Year Award Is A Big Deal
    5/9/2011

    On Thursday, May 5, 2011, the Healthcare Businesswomen’s Association (HBA) celebrated its Woman of the Year Award (WOTY) via a luncheon in New York City.

  • The Circle Of Influence
    5/5/2011

    A couple of months ago I wrote a blog about social media (SM), whereby I pointed out my SM inadequacies. I have been making a concerted effort to improve my SM knowledge base and use of this communication tool. By  Rob Wright

  • The Pink Male Elephant In The Room
    4/27/2011

    Since becoming the chief editor of Life Science Leader magazine, I have had the opportunity to attend a variety of trade shows and conferences. Several things have become apparent to me.

  • Vendor Audits: A Complex Process
    4/27/2011

    Back in March, a reader wrote to me about my article “Buttoning Down the Pharma Supply Chain” in the February issue. We had an email dialogue, and I blogged about it (see “Reader Responds: Vendor Audits Are A Waste”). By  Rob Wright

  • Disincentives To Adopting New Drug Delivery Systems
    4/11/2011

    Scientists from the University of Syracuse chemistry department recently created a new drug delivery system which uses gold nanoparticles with attached DNA designed to bind to Doxorubin, an anticancer drug. By  Rob Wright

  • Rising From The Ashes With Accelerating Urgency
    4/5/2011

    This year’s Partnerships in Clinical Trials trade show was appropriately held at the Phoenix Convention Center in Arizona. I say appropriate because the pharmaceutical industry is at a point of renewal and change, similar to the phoenix. By  Rob Wright

  • Bought In To Buy In
    4/4/2011

    Ever hear of John Kotter? He has written 17 books, all in the top 1% of sales from Amazon.com. He is probably most well known for his international bestseller, Leading Change, which outlined an eight-step process for implementing successful transformations. By  Rob Wright

  • Is It The Sizzle Or The Steak
    3/28/2011

    Having somewhat of a marketing background, I tend to be a little on the skeptical side when I see marketing and promotional announcements. By  Rob Wright

Rob Wright author page

Rob Wright

Rob Wright was chief editor of Life Science Leader magazine from 2011-2021. Prior to joining the publication, he spent nearly 20 years in the pharmaceutical industry. During his industry career, Wright conducted well over 1,000 presentations and roundtable discussions, including the facilitation of FDA-mandated clinical training programs for hundreds of licensed healthcare providers. He has chaired, moderated, and served as a speaker at industry and academic conferences, and served as co-chair for the 2015 and 2018 BIO International conference’s educational planning committee. Wright’s 500+ published articles have appeared in peer-reviewed academic journals, B2B magazines and online publications. He received a B.S. in Business Administration from Indiana University of Pennsylvania, MBA with distinction from Gannon University, and completed his doctoral coursework in marketing at Cleveland State University. He is a member of international business honor societies Sigma Beta Delta and Beta Gamma Sigma. He can be followed on Twitter @RfwrightLSL